CoChat

Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors

Feuring-Buske, M, Gerhard, B, Cashman, J, Humphries, R K, Eaves, C J, Hogge, D E · 2003 · Leukemia

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Primitive malignant progenitors defined as nonobese diabetic/severe combined immunodeficient (NOD/SCID) leukemia-initiating cells or NOD/SL-IC from patients with acute myeloid leukemia (AML) can be detected and quantitated in sublethally irradiated NOD/SCID mice. However, there is variability in the levels of bone marrow (BM) engraftment obtained after intravenous injection of cells from different AML samples. In the current study, AML cell engraftment in standard NOD/SCID mice was compared to that obtained with NOD/SCID mice transgenic for the human growth factor genes Steel factor (SF), interleukin-3 (IL-3) and granulocyte macrophage-colony-stimulating factor (GM-CSF) (N/S-S/GM/3) as well as beta 2 microglobulin-null NOD/SCID (N/S-beta 2m(-/-)) mice. Three of the eight AML samples that failed to engraft in standard NOD/SCID animals showed easily detectable and up to 70-fold increased in the number of leukemic cells in BM 8-12 weeks post-transplantation in each of the N/S-beta 2m(-/-) and N/S-S/GM/3 mouse strains. In two of the four AML samples studied at limiting dilution, the frequency of NOD/SL-IC detected was increased six- and seven-fold. Thus, in these novel mouse strains a broader spectrum of AML patient samples can be evaluated for their progenitor content and potentially studied for their response to innovative therapeutics in vivo.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.leu.2402882

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Research works printed but not linked: 1

  1. Nicolini FE, Cashman JD, Humphries RK, Eaves CJ . Transplantation of human marrow in NOD/SCID mice genetically engineered to continuously produce human IL-3, GM-CSF and Steel Factor (SF) results in increased numbers of human progenitors in the circulation without compromising overall engraftment. Blood 2000; 96: 292a (Abstract).

Cited by

See all 116

Metadata

Authors
Feuring-Buske, M., Gerhard, B., Cashman, J., Humphries, R. K., Eaves, C. J., & Hogge, D. E.
Affiliations
BC Cancer Agency (CA)
Venue
Leukemia
Published
2003-04-01
Volume
17
Issue
4
Pages
760-763
ISSN
  • 0887-6924 (ISSN-L)
  • 1476-5551
OpenAlex
W1999453504
Cited by
116
References
22
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 5 · 2020: 8 · 2019: 6 · 2018: 7 · 2017: 5 · 2016: 9 · 2015: 6 · 2014: 2 · 2013: 12 · 2012: 7
FWCI
1.13
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Leukemia (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsche Krebshilfe
  • National Cancer Institute
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords
acute myeloid leukemia, leukemia-initiating cells, NOD/SCID mice, transgenic mice, stem cell factor, interleukin-3, GM-CSF, bone marrow engraftment, limiting dilution
MeSH terms
Acute Disease, Animals, beta 2-Microglobulin, Bone Marrow, Flow Cytometry, Graft Survival, Humans, Interleukin-3, Leukemia, Myeloid, Mice, Transgenic, Neoplasm Transplantation, Radiation Chimera, Recombinant Fusion Proteins, Transplantation, Heterologous, Granulocyte-Macrophage Colony-Stimulating Factor, Mice, SCID, Mice, Inbred NOD, In Situ Hybridization, Fluorescence, Mice, Knockout, Stem Cell Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors. https://app.cochat.ai/papers/10.1038/sj.leu.2402882
The paper
Feuring-Buske, M., Gerhard, B., Cashman, J., Humphries, R. K., Eaves, C. J., & Hogge, D. E. (2003). Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors. Leukemia. https://doi.org/10.1038/sj.leu.2402882

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.